137 related articles for article (PubMed ID: 20619552)
1. High-dose split-course radiation therapy for anal cancer: outcome analysis regarding the boost strategy (CORS-03 study).
Hannoun-Levi JM; Ortholan C; Resbeut M; Teissier E; Ronchin P; Cowen D; Zaccariotto A; Bénézery K; François E; Salem N; Ellis S; Azria D; Gerard JP
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):712-20. PubMed ID: 20619552
[TBL] [Abstract][Full Text] [Related]
2. Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 study).
Moureau-Zabotto L; Ortholan C; Hannoun-Levi JM; Teissier E; Cowen D; Salem N; Lemanski C; Ellis S; Resbeut M
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e135-42. PubMed ID: 23195780
[TBL] [Abstract][Full Text] [Related]
3. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
[TBL] [Abstract][Full Text] [Related]
4. Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy.
Ortholan C; Ramaioli A; Peiffert D; Lusinchi A; Romestaing P; Chauveinc L; Touboul E; Peignaux K; Bruna A; de La Roche G; Lagrange JL; Alzieu C; Gerard JP
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):479-85. PubMed ID: 15890590
[TBL] [Abstract][Full Text] [Related]
5. [Radiotherapy of carcinomas of the anal canal. Tenon Hospital experience].
Touboul E; Moureau-Zabotto L; Lerouge D; Pène F; Deniaud-Alexandre E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Schlienger M; Laugier A
Cancer Radiother; 2003 Nov; 7 Suppl 1():91s-99s. PubMed ID: 15124550
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.
Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF
Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244
[TBL] [Abstract][Full Text] [Related]
7. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients.
Touboul E; Schlienger M; Buffat L; Lefkopoulos D; Pène F; Parc R; Tiret E; Gallot D; Malafosse M; Laugier A
Cancer; 1994 Mar; 73(6):1569-79. PubMed ID: 8156483
[TBL] [Abstract][Full Text] [Related]
8. [The anal canal: 2 cycles of radiochemotherapy and boost brachytherapy].
Valentini V; Mantello G; Luzi S; Genovesi D; Smaniotto D; Mantini G; Coco C; Ratto C; Sofo L; Cellini N
Radiol Med; 1997 Apr; 93(4):451-6. PubMed ID: 9244925
[TBL] [Abstract][Full Text] [Related]
9. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
[TBL] [Abstract][Full Text] [Related]
10. [The treatment of cancer of the anal area with radiotherapy. An analysis of the authors' personal experience].
Pizzi G; Mandoliti G; Guglielmi R; Fongione S; Beorchia A; Ceschia T; Cereghini M
Radiol Med; 1990 May; 79(5):530-3. PubMed ID: 2359861
[TBL] [Abstract][Full Text] [Related]
11. Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: a retrospective study.
Bruna A; Gastelblum P; Thomas L; Chapet O; Bollet MA; Ardiet JM; Gérard JP; Peiffert D
Radiother Oncol; 2006 Apr; 79(1):75-9. PubMed ID: 16631268
[TBL] [Abstract][Full Text] [Related]
12. Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers.
Cordoba A; Escande A; Leroy T; Mirabel X; Coche-Dequéant B; Lartigau E
Brachytherapy; 2017; 16(1):230-235. PubMed ID: 27600606
[TBL] [Abstract][Full Text] [Related]
13. Interstitial high-dose rate brachytherapy as boost for anal canal cancer.
Falk AT; Claren A; Benezery K; François E; Gautier M; Gerard JP; Hannoun-Levi JM
Radiat Oncol; 2014 Nov; 9():240. PubMed ID: 25377886
[TBL] [Abstract][Full Text] [Related]
14. The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer.
Saarilahti K; Arponen P; Vaalavirta L; Tenhunen M
Radiother Oncol; 2008 Jun; 87(3):383-90. PubMed ID: 18501454
[TBL] [Abstract][Full Text] [Related]
15. High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx.
Rudoltz MS; Perkins RS; Luthmann RW; Fracke TD; Green TM; Moye L; Wludyka P; Choi YK; Ackerman SN
Laryngoscope; 1999 Dec; 109(12):1967-73. PubMed ID: 10591356
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
Myerson RJ; Outlaw ED; Chang A; Birnbaum EH; Fleshman JW; Grigsby PW; Kodner IJ; Malayapa RS; Mutch MG; Parikh P; Picus J; Tan BR
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):428-35. PubMed ID: 19251377
[TBL] [Abstract][Full Text] [Related]
17. Radiation dose associated with local control in advanced anal cancer: retrospective analysis of 129 patients.
Widder J; Kastenberger R; Fercher E; Schmid R; Langendijk JA; Dobrowsky W; Pötter R
Radiother Oncol; 2008 Jun; 87(3):367-75. PubMed ID: 18501453
[TBL] [Abstract][Full Text] [Related]
18. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
[TBL] [Abstract][Full Text] [Related]
19. [Combination of endoscopic resection and external radiotherapy in carcinoma of the bladder].
Kahlain A; Bouras N; Sahraoui S; Acharki A; Benider A; Samlali R
Cancer Radiother; 1998 Apr; 2 Suppl 1():31s-33s. PubMed ID: 9749075
[TBL] [Abstract][Full Text] [Related]
20. [The role of surgery in the treatment of epidermoid cancer of the anal canal].
Lombard-Platet R
Ann Gastroenterol Hepatol (Paris); 1994 Sep; 30(4):185-8. PubMed ID: 7979153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]